{"id":1157,"date":"2026-07-16T13:59:01","date_gmt":"2026-07-16T11:59:01","guid":{"rendered":"https:\/\/infoimasd.com\/?p=1157"},"modified":"2026-07-16T13:59:02","modified_gmt":"2026-07-16T11:59:02","slug":"csic-cortistatina-potencial-terapeutico-ictus","status":"publish","type":"post","link":"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/","title":{"rendered":"Un estudio del CSIC identifica una mol\u00e9cula con potencial para reducir el da\u00f1o cerebral tras un ictus"},"content":{"rendered":"\n<p class=\"has-medium-font-size wp-block-paragraph\">Una investigaci\u00f3n liderada por el <strong><a href=\"https:\/\/www.csic.es\/es\/actualidad-del-csic\/una-molecula-del-organismo-reduce-la-inflamacion-y-el-dano-cerebral-tras-un-ictus-segun-un-estudio-preclinico-del-csic\" data-type=\"link\" data-id=\"https:\/\/www.csic.es\/es\/actualidad-del-csic\/una-molecula-del-organismo-reduce-la-inflamacion-y-el-dano-cerebral-tras-un-ictus-segun-un-estudio-preclinico-del-csic\">Instituto de Parasitolog\u00eda y Biomedicina L\u00f3pez-Neyra (IPBLN-CSIC)<\/a> ha identificado una nueva v\u00eda terap\u00e9utica para el tratamiento del ictus isqu\u00e9mico.<\/strong> El estudio demuestra por primera vez en un modelo animal que<strong> la mol\u00e9cula cortistatina<\/strong>, conocida hasta ahora por su papel en la regulaci\u00f3n del sue\u00f1o y del sistema inmunitario, tambi\u00e9n <strong>act\u00faa como un regulador natural de la respuesta neuroinmunitaria tras un infarto cerebral.<\/strong><\/p>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">Los resultados, publicados en la revista Journal of Biomedical Science, muestran que <strong>esta mol\u00e9cula interviene simult\u00e1neamente en tres procesos clave para limitar el da\u00f1o cerebral<\/strong>: la inflamaci\u00f3n, la integridad de los vasos sangu\u00edneos y la supervivencia de las neuronas. La investigaci\u00f3n ha sido liderada por la doctora Elena Gonz\u00e1lez-Rey, del IPBLN-<a href=\"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-memoria-anual-2025-publicaciones-cientificas-innovacion\/\" data-type=\"post\" data-id=\"1151\">CSIC<\/a>, en colaboraci\u00f3n con la doctora Julia Castillo-Gonz\u00e1lez, del Hospital Universitario de Lausanne (Suiza). Los investigadores consideran que este hallazgo abre la <strong>puerta al desarrollo de nuevas estrategias terap\u00e9uticas<\/strong> para una enfermedad que contin\u00faa teniendo opciones de tratamiento limitadas. Adem\u00e1s, ofrece una posible explicaci\u00f3n de por qu\u00e9 algunos pacientes presentan una evoluci\u00f3n mucho peor que otros tras sufrir un ictus.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Un regulador natural frente al da\u00f1o cerebral<\/h3>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">Para analizar el papel de la cortistatina, el equipo combin\u00f3 estudios moleculares realizados en pacientes que hab\u00edan sufrido un ictus con experimentos precl\u00ednicos en modelos animales. Los ensayos incluyeron ratones modificados gen\u00e9ticamente para carecer de esta <a href=\"https:\/\/infoimasd.com\/index.php\/2026\/06\/19\/la-investigacion-de-molefy-pharma-que-da-esperanza-frente-a-la-ela\/\" data-type=\"post\" data-id=\"758\">mol\u00e9cula<\/a> lo que permiti\u00f3 evaluar c\u00f3mo respond\u00eda el cerebro a la isquemia en su ausencia. Los resultados mostraron que <strong>los niveles de cortistatina disminuyen de forma significativa despu\u00e9s de un ictus, tanto en personas como en animales, y que esa reducci\u00f3n est\u00e1 relacionada con una mayor gravedad del cuadro cl\u00ednico.<\/strong><\/p>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">Adem\u00e1s, cuando el organismo carece de esta mol\u00e9cula, el cerebro presenta una respuesta inflamatoria m\u00e1s intensa, mayor deterioro vascular y un incremento del da\u00f1o neuronal provocado por la falta de riego sangu\u00edneo. Seg\u00fan las investigadoras, estos resultados indican que <strong>la cortistatina forma parte de los mecanismos naturales que utiliza el organismo para limitar el da\u00f1o cerebral tras un ictus y favorecer la recuperaci\u00f3n del tejido afectado.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Mejora la recuperaci\u00f3n incluso varios d\u00edas despu\u00e9s del ictus<\/h3>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">El estudio evalu\u00f3 tambi\u00e9n el potencial terap\u00e9utico de la administraci\u00f3n de cortistatina como tratamiento, tanto durante la fase aguda del ictus (las primeras 48 horas) como en la fase subaguda (hasta siete d\u00edas despu\u00e9s del episodio). En ambos escenarios, <strong>la <a href=\"https:\/\/infoimasd.com\/index.php\/2026\/06\/22\/ap-2-la-prometedora-molecula-candidata-de-molefy-pharma-para-frenar-la-ela\/\" data-type=\"post\" data-id=\"797\">mol\u00e9cula<\/a> mostr\u00f3 efectos neuroprotectores relevantes.<\/strong> El tratamiento favoreci\u00f3 la supervivencia de las neuronas, redujo la sobreactivaci\u00f3n del sistema inmunitario, preserv\u00f3 la integridad de los vasos sangu\u00edneos y protegi\u00f3 la mielina (capa que recubre los axones) y permite la correcta comunicaci\u00f3n entre las neuronas.<\/p>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">Los efectos beneficiosos se observaron tanto en animales j\u00f3venes como adultos, un resultado que refuerza el potencial de trasladar estos hallazgos a futuras investigaciones cl\u00ednicas. Las autoras destacan que <strong>la principal fortaleza de la cortistatina es su capacidad para actuar sobre m\u00faltiples mecanismos implicados en el da\u00f1o cerebral<\/strong>. Un hecho que la diferencia de los tratamientos actuales que suelen dirigirse a un \u00fanico proceso y est\u00e1n limitados a las primeras horas tras el ictus.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Hacia tratamientos m\u00e1s personalizados<\/h3>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">La investigaci\u00f3n tambi\u00e9n apunta a que la cortistatina podr\u00eda convertirse en un <strong>biomarcador \u00fatil para identificar a los pacientes con mayor riesgo<\/strong> de desarrollar complicaciones tras un infarto cerebral. Comprender c\u00f3mo evolucionan sus niveles despu\u00e9s del ictus podr\u00eda ayudar a explicar las diferencias en la recuperaci\u00f3n entre pacientes y facilitar el desarrollo de terapias m\u00e1s personalizadas. Los investigadores consideran que el trabajo representa un <strong>avance significativo en la b\u00fasqueda de tratamientos<\/strong> capaces de reducir el da\u00f1o cerebral m\u00e1s all\u00e1 de la fase hiperaguda del ictus.<\/p>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\"><strong>El ictus isqu\u00e9mico constituye la principal causa de discapacidad adquirida en el mundo y la segunda causa de mortalidad.<\/strong> Se produce cuando el flujo sangu\u00edneo hacia una parte del cerebro se interrumpe de forma brusca, provocando la muerte de neuronas por falta de ox\u00edgeno. En la actualidad, las terapias disponibles se centran fundamentalmente en restablecer la circulaci\u00f3n sangu\u00ednea. Sin embargo, <strong>no existen tratamientos dirigidos a controlar los procesos inflamatorios, el deterioro vascular o la muerte progresiva de neuronas <\/strong>que contin\u00faan produci\u00e9ndose durante los d\u00edas posteriores al episodio. En este contexto, los resultados obtenidos por el equipo del IPBLN-<a href=\"https:\/\/infoimasd.com\/index.php\/2026\/07\/01\/santander-csic-acuerdo-inteligencia-artificial-sector-financiero\/\" data-type=\"post\" data-id=\"911\">CSIC <\/a>ofrecen una <strong>nueva perspectiva para desarrollar terapias que tambi\u00e9n reduzcan las secuelas y mejoren la recuperaci\u00f3n <\/strong>funcional de los pacientes a medio y largo plazo.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La investigaci\u00f3n demuestra por primera vez en un modelo animal que la cortistatina protege el cerebro al actuar sobre la inflamaci\u00f3n, los vasos sangu\u00edneos y la supervivencia de las neuronas.<\/p>\n","protected":false},"author":1,"featured_media":1159,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[11],"tags":[461,179,459,173,460,462],"class_list":["post-1157","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-investigacion","tag-cortistatina","tag-csic","tag-ictus","tag-investigacion-biomedica","tag-neurociencia","tag-neuroproteccion"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Un estudio del CSIC identifica una mol\u00e9cula con potencial para reducir el da\u00f1o cerebral tras un ictus - INFO I+D<\/title>\n<meta name=\"description\" content=\"El CSIC demuestra que la cortistatina protege el cerebro tras un ictus al reducir la inflamaci\u00f3n, preservar los vasos sangu\u00edneos y las neuronas.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un estudio del CSIC identifica una mol\u00e9cula con potencial para reducir el da\u00f1o cerebral tras un ictus - INFO I+D\" \/>\n<meta property=\"og:description\" content=\"El CSIC demuestra que la cortistatina protege el cerebro tras un ictus al reducir la inflamaci\u00f3n, preservar los vasos sangu\u00edneos y las neuronas.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/\" \/>\n<meta property=\"og:site_name\" content=\"INFO I+D\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-16T11:59:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-16T11:59:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/07\/Molecula-CSIC-Ictus.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1112\" \/>\n\t<meta property=\"og:image:height\" content=\"804\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Miguel Guti\u00e9rrez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Miguel Guti\u00e9rrez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/16\\\/csic-cortistatina-potencial-terapeutico-ictus\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/16\\\/csic-cortistatina-potencial-terapeutico-ictus\\\/\"},\"author\":{\"name\":\"Miguel Guti\u00e9rrez\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#\\\/schema\\\/person\\\/7d19b1faaeac5b8ab56fbdb8f46fc85e\"},\"headline\":\"Un estudio del CSIC identifica una mol\u00e9cula con potencial para reducir el da\u00f1o cerebral tras un ictus\",\"datePublished\":\"2026-07-16T11:59:01+00:00\",\"dateModified\":\"2026-07-16T11:59:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/16\\\/csic-cortistatina-potencial-terapeutico-ictus\\\/\"},\"wordCount\":814,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/16\\\/csic-cortistatina-potencial-terapeutico-ictus\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Molecula-CSIC-Ictus.jpg\",\"keywords\":[\"cortistatina\",\"CSIC\",\"ictus\",\"Investigaci\u00f3n biom\u00e9dica\",\"neurociencia\",\"neuroprotecci\u00f3n\"],\"articleSection\":[\"Investigaci\u00f3n\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/16\\\/csic-cortistatina-potencial-terapeutico-ictus\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/16\\\/csic-cortistatina-potencial-terapeutico-ictus\\\/\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/16\\\/csic-cortistatina-potencial-terapeutico-ictus\\\/\",\"name\":\"Un estudio del CSIC identifica una mol\u00e9cula con potencial para reducir el da\u00f1o cerebral tras un ictus - INFO I+D\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/16\\\/csic-cortistatina-potencial-terapeutico-ictus\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/16\\\/csic-cortistatina-potencial-terapeutico-ictus\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Molecula-CSIC-Ictus.jpg\",\"datePublished\":\"2026-07-16T11:59:01+00:00\",\"dateModified\":\"2026-07-16T11:59:02+00:00\",\"description\":\"El CSIC demuestra que la cortistatina protege el cerebro tras un ictus al reducir la inflamaci\u00f3n, preservar los vasos sangu\u00edneos y las neuronas.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/16\\\/csic-cortistatina-potencial-terapeutico-ictus\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/16\\\/csic-cortistatina-potencial-terapeutico-ictus\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/16\\\/csic-cortistatina-potencial-terapeutico-ictus\\\/#primaryimage\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Molecula-CSIC-Ictus.jpg\",\"contentUrl\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Molecula-CSIC-Ictus.jpg\",\"width\":1112,\"height\":804},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/16\\\/csic-cortistatina-potencial-terapeutico-ictus\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/infoimasd.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un estudio del CSIC identifica una mol\u00e9cula con potencial para reducir el da\u00f1o cerebral tras un ictus\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#website\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/\",\"name\":\"infoimasd.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/infoimasd.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#organization\",\"name\":\"INFO I+D\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Logo-INFO-ID-RELIEVE-150-X-150.png\",\"contentUrl\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Logo-INFO-ID-RELIEVE-150-X-150.png\",\"width\":1254,\"height\":1254,\"caption\":\"INFO I+D\"},\"image\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#\\\/schema\\\/person\\\/7d19b1faaeac5b8ab56fbdb8f46fc85e\",\"name\":\"Miguel Guti\u00e9rrez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/litespeed\\\/avatar\\\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1790012860\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/litespeed\\\/avatar\\\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1790012860\",\"contentUrl\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/litespeed\\\/avatar\\\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1790012860\",\"caption\":\"Miguel Guti\u00e9rrez\"},\"description\":\"Director de INFO I+D\",\"sameAs\":[\"https:\\\/\\\/infoimasd.com\\\/\"],\"url\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/author\\\/admin8536\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un estudio del CSIC identifica una mol\u00e9cula con potencial para reducir el da\u00f1o cerebral tras un ictus - INFO I+D","description":"El CSIC demuestra que la cortistatina protege el cerebro tras un ictus al reducir la inflamaci\u00f3n, preservar los vasos sangu\u00edneos y las neuronas.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/","og_locale":"es_ES","og_type":"article","og_title":"Un estudio del CSIC identifica una mol\u00e9cula con potencial para reducir el da\u00f1o cerebral tras un ictus - INFO I+D","og_description":"El CSIC demuestra que la cortistatina protege el cerebro tras un ictus al reducir la inflamaci\u00f3n, preservar los vasos sangu\u00edneos y las neuronas.","og_url":"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/","og_site_name":"INFO I+D","article_published_time":"2026-07-16T11:59:01+00:00","article_modified_time":"2026-07-16T11:59:02+00:00","og_image":[{"width":1112,"height":804,"url":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/07\/Molecula-CSIC-Ictus.jpg","type":"image\/jpeg"}],"author":"Miguel Guti\u00e9rrez","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Miguel Guti\u00e9rrez","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/#article","isPartOf":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/"},"author":{"name":"Miguel Guti\u00e9rrez","@id":"https:\/\/infoimasd.com\/#\/schema\/person\/7d19b1faaeac5b8ab56fbdb8f46fc85e"},"headline":"Un estudio del CSIC identifica una mol\u00e9cula con potencial para reducir el da\u00f1o cerebral tras un ictus","datePublished":"2026-07-16T11:59:01+00:00","dateModified":"2026-07-16T11:59:02+00:00","mainEntityOfPage":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/"},"wordCount":814,"commentCount":0,"publisher":{"@id":"https:\/\/infoimasd.com\/#organization"},"image":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/#primaryimage"},"thumbnailUrl":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/07\/Molecula-CSIC-Ictus.jpg","keywords":["cortistatina","CSIC","ictus","Investigaci\u00f3n biom\u00e9dica","neurociencia","neuroprotecci\u00f3n"],"articleSection":["Investigaci\u00f3n"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/","url":"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/","name":"Un estudio del CSIC identifica una mol\u00e9cula con potencial para reducir el da\u00f1o cerebral tras un ictus - INFO I+D","isPartOf":{"@id":"https:\/\/infoimasd.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/#primaryimage"},"image":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/#primaryimage"},"thumbnailUrl":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/07\/Molecula-CSIC-Ictus.jpg","datePublished":"2026-07-16T11:59:01+00:00","dateModified":"2026-07-16T11:59:02+00:00","description":"El CSIC demuestra que la cortistatina protege el cerebro tras un ictus al reducir la inflamaci\u00f3n, preservar los vasos sangu\u00edneos y las neuronas.","breadcrumb":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/#primaryimage","url":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/07\/Molecula-CSIC-Ictus.jpg","contentUrl":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/07\/Molecula-CSIC-Ictus.jpg","width":1112,"height":804},{"@type":"BreadcrumbList","@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/16\/csic-cortistatina-potencial-terapeutico-ictus\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/infoimasd.com\/"},{"@type":"ListItem","position":2,"name":"Un estudio del CSIC identifica una mol\u00e9cula con potencial para reducir el da\u00f1o cerebral tras un ictus"}]},{"@type":"WebSite","@id":"https:\/\/infoimasd.com\/#website","url":"https:\/\/infoimasd.com\/","name":"infoimasd.com","description":"","publisher":{"@id":"https:\/\/infoimasd.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/infoimasd.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/infoimasd.com\/#organization","name":"INFO I+D","url":"https:\/\/infoimasd.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/infoimasd.com\/#\/schema\/logo\/image\/","url":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/05\/Logo-INFO-ID-RELIEVE-150-X-150.png","contentUrl":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/05\/Logo-INFO-ID-RELIEVE-150-X-150.png","width":1254,"height":1254,"caption":"INFO I+D"},"image":{"@id":"https:\/\/infoimasd.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/infoimasd.com\/#\/schema\/person\/7d19b1faaeac5b8ab56fbdb8f46fc85e","name":"Miguel Guti\u00e9rrez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/infoimasd.com\/wp-content\/litespeed\/avatar\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1790012860","url":"https:\/\/infoimasd.com\/wp-content\/litespeed\/avatar\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1790012860","contentUrl":"https:\/\/infoimasd.com\/wp-content\/litespeed\/avatar\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1790012860","caption":"Miguel Guti\u00e9rrez"},"description":"Director de INFO I+D","sameAs":["https:\/\/infoimasd.com\/"],"url":"https:\/\/infoimasd.com\/index.php\/author\/admin8536\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/07\/Molecula-CSIC-Ictus.jpg","_links":{"self":[{"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/posts\/1157","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/comments?post=1157"}],"version-history":[{"count":3,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/posts\/1157\/revisions"}],"predecessor-version":[{"id":1161,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/posts\/1157\/revisions\/1161"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/media\/1159"}],"wp:attachment":[{"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/media?parent=1157"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/categories?post=1157"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/tags?post=1157"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}